Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
Paul Emery,Clifton O. Bingham,Gerd R Burmester,Vivian P. Bykerk,Daniel E. Furst,Xavier Mariette,Désirée van der Heijde,Ronald van Vollenhoven,Catherine Arendt,Irina Mountian,O. Purcaru,Daljit Tatla,B. VanLunen,Michael E. Weinblatt
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
Criminology34
BowieHuang
轨迹
Mufreh
寻道图强
有人
toutou
无极微光
AN
微微旺旺
劉浏琉
Ming
lanxinyue
sys549
NattyPoe
帝国之花
轻松大王
pluto
Rita
morena
Wind
安鹏
MchemG
皖公网安备34019202002308
